Monitoring medication adherence by unannounced pill counts conducted by telephone: Reliability and criterion-related validity

HIV Clinical Trials

Volumn 9, Issue 5, 2008, Pages 298-308

  Kalichman, Seth C ^a   Amaral, Christina M ^a   Cherry, Chauncey ^a   Flanagan, Jody ^a   Pope, Howard ^a   Eaton, Lisa ^a   Kalichman, Moira O ^a   Cain, Demetria ^a   Detorio, Mervi ^b   Caliendo, Angela ^b   Schinazi, Raymond F ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence assessment; HIV AIDS treatment; Medication adherence; Medication monitoring; Pill counts

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CRITERION RELATED VALIDITY; DRUG MONITORING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELIABILITY; TELEPHONE; UNITED STATES; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; VIRAL LOAD;

EID: 57149107997     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct0905-298     Document Type: Article

References (19)

1. Bangsberg DR, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65-72.
2. Kalichman DC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: Prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDs. 2005;19:49-55.
3. Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis. Clin Infect Dis. 2007;45:908-915.
4. Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227-331.
5. Wagner G, Miller LG. Is the influence of social desirability on patient's self-reported adherence overrated? J Acquir Immune Defic Syndr. 2004;36:203-204.
6. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26:435-442.
7. Grossberg R., Gross R. Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep. 2007;4:187-191.
8. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968-977.
9. Rabkin JG, Chesney M. Treatment adherence to HIV medications: The Archilles heel of the new therapeutics. In: Ostrow D, Kalichman S, eds. Behavioral and Mental Health Impacts of New HIV Therapies. New York: Plenum Press; 1999.
10. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
11. Kalichman SC, Amaral CM, Stearns H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22:1003-1006.
12. Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275-281.
13. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
14. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: Adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am. 2007; 21:181-200.
15. Baker DW, Parker RM, Williams MV, Clark WS. Health literacy and the risk of hospital admission. J Gen Int Med. 1998;13:791-798.
16. Babor TF, de la Fuente JR, Saunders J, Grant M. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. Geneva: World Health Care Organization; 1992.
17. Beck AT, Steer RA. BDI: Beck Depression Inventory Manual. New York: Psychological Corporation; 1983.
18. Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV/ AIDS. J Nervous Ment Dis. 2000;188:662-670.
19. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Int Med. 2000; 133:21-30.